Published in:
Volume 2 / Year 2013 / Issue 1

The case for biosimilars–a payer’s perspective

Page: 12

Abstract:  Biosimilars have the potential for making savings in healthcare costs, and with resource allocation, if competition is permitted at the level of treatment induction. Submitted: 24 August 2012; Revised: 17 January 2013; Accepted: 4… Read More »

Go Back Print